Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C24H31ClO7 |
Molecular Weight | 466.952 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@](OC(=O)OCC)(C(=O)OCCl)[C@@]1(C)C[C@H](O)[C@@]3([H])[C@@]2([H])CCC4=CC(=O)C=C[C@]34C
InChI
InChIKey=DMKSVUSAATWOCU-HROMYWEYSA-N
InChI=1S/C24H31ClO7/c1-4-30-21(29)32-24(20(28)31-13-25)10-8-17-16-6-5-14-11-15(26)7-9-22(14,2)19(16)18(27)12-23(17,24)3/h7,9,11,16-19,27H,4-6,8,10,12-13H2,1-3H3/t16-,17-,18-,19+,22-,23-,24-/m0/s1
Molecular Formula | C24H31ClO7 |
Molecular Weight | 466.952 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Cmax
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
621 ng/mL EXPERIMENT https://www.ncbi.nlm.nih.gov/pubmed/25134493 |
0.5 μg single, intraocular dose: 0.5 μg route of administration: Intraocular experiment type: SINGLE co-administered: |
LOTEPREDNOL cornea | Oryctolagus cuniculus population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
AUC
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
1130 ng × h/mL EXPERIMENT https://www.ncbi.nlm.nih.gov/pubmed/25134493 |
0.5 μg single, intraocular dose: 0.5 μg route of administration: Intraocular experiment type: SINGLE co-administered: |
LOTEPREDNOL cornea | Oryctolagus cuniculus population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
T1/2
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
3.75 h EXPERIMENT https://www.ncbi.nlm.nih.gov/pubmed/25134493 |
0.5 μg single, intraocular dose: 0.5 μg route of administration: Intraocular experiment type: SINGLE co-administered: |
LOTEPREDNOL cornea | Oryctolagus cuniculus population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN |
Funbound
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
2% EXPERIMENT https://www.ncbi.nlm.nih.gov/pubmed/28017774 |
LOTEPREDNOL plasma | Homo sapiens population: UNKNOWN age: UNKNOWN sex: UNKNOWN food status: UNKNOWN |
Doses
Dose | Population | Adverse events |
---|---|---|
1 drop 4 times / day multiple, topical Recommended Dose: 1 drop, 4 times / day Route: topical Route: multiple Dose: 1 drop, 4 times / day Sources: Page: p.461 |
unhealthy, 3.4 ± 1.1 n = 109 Health Status: unhealthy Condition: Giant papillary conjunctivitis Age Group: 3.4 ± 1.1 Sex: M+F Population Size: 109 Sources: Page: p.461 |
Disc. AE: Intraocular pressure increased... AEs leading to discontinuation/dose reduction: Intraocular pressure increased (2.8%) Sources: Page: p.461 |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Intraocular pressure increased | 2.8% Disc. AE |
1 drop 4 times / day multiple, topical Recommended Dose: 1 drop, 4 times / day Route: topical Route: multiple Dose: 1 drop, 4 times / day Sources: Page: p.461 |
unhealthy, 3.4 ± 1.1 n = 109 Health Status: unhealthy Condition: Giant papillary conjunctivitis Age Group: 3.4 ± 1.1 Sex: M+F Population Size: 109 Sources: Page: p.461 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:46:48 GMT 2023
by
admin
on
Fri Dec 15 15:46:48 GMT 2023
|
Record UNII |
YEH1EZ96K6
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C521
Created by
admin on Fri Dec 15 15:46:49 GMT 2023 , Edited by admin on Fri Dec 15 15:46:49 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID2046468
Created by
admin on Fri Dec 15 15:46:49 GMT 2023 , Edited by admin on Fri Dec 15 15:46:49 GMT 2023
|
PRIMARY | |||
|
YEH1EZ96K6
Created by
admin on Fri Dec 15 15:46:49 GMT 2023 , Edited by admin on Fri Dec 15 15:46:49 GMT 2023
|
PRIMARY | |||
|
YEH1EZ96K6
Created by
admin on Fri Dec 15 15:46:49 GMT 2023 , Edited by admin on Fri Dec 15 15:46:49 GMT 2023
|
PRIMARY | |||
|
DB00873
Created by
admin on Fri Dec 15 15:46:49 GMT 2023 , Edited by admin on Fri Dec 15 15:46:49 GMT 2023
|
PRIMARY | |||
|
52177
Created by
admin on Fri Dec 15 15:46:49 GMT 2023 , Edited by admin on Fri Dec 15 15:46:49 GMT 2023
|
PRIMARY | RxNorm | ||
|
m6912
Created by
admin on Fri Dec 15 15:46:49 GMT 2023 , Edited by admin on Fri Dec 15 15:46:49 GMT 2023
|
PRIMARY | Merck Index | ||
|
100000076769
Created by
admin on Fri Dec 15 15:46:49 GMT 2023 , Edited by admin on Fri Dec 15 15:46:49 GMT 2023
|
PRIMARY | |||
|
7085
Created by
admin on Fri Dec 15 15:46:49 GMT 2023 , Edited by admin on Fri Dec 15 15:46:49 GMT 2023
|
PRIMARY | |||
|
BB-79
Created by
admin on Fri Dec 15 15:46:49 GMT 2023 , Edited by admin on Fri Dec 15 15:46:49 GMT 2023
|
PRIMARY | |||
|
SUB14390MIG
Created by
admin on Fri Dec 15 15:46:49 GMT 2023 , Edited by admin on Fri Dec 15 15:46:49 GMT 2023
|
PRIMARY | |||
|
CHEMBL1200865
Created by
admin on Fri Dec 15 15:46:49 GMT 2023 , Edited by admin on Fri Dec 15 15:46:49 GMT 2023
|
PRIMARY | |||
|
444025
Created by
admin on Fri Dec 15 15:46:49 GMT 2023 , Edited by admin on Fri Dec 15 15:46:49 GMT 2023
|
PRIMARY | |||
|
82034-46-6
Created by
admin on Fri Dec 15 15:46:49 GMT 2023 , Edited by admin on Fri Dec 15 15:46:49 GMT 2023
|
PRIMARY | |||
|
C47589
Created by
admin on Fri Dec 15 15:46:49 GMT 2023 , Edited by admin on Fri Dec 15 15:46:49 GMT 2023
|
PRIMARY | |||
|
1611
Created by
admin on Fri Dec 15 15:46:49 GMT 2023 , Edited by admin on Fri Dec 15 15:46:49 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|